Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 2
1990 3
1992 4
1993 4
1995 3
1996 2
1997 2
1998 1
1999 2
2000 2
2001 2
2002 1
2003 2
2004 3
2005 2
2006 2
2007 4
2008 6
2009 7
2010 2
2011 6
2012 7
2013 6
2014 10
2015 6
2016 4
2017 10
2018 10
2019 15
2020 8
2021 8
2022 5
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia.
Staber PB, Herling M, Bellido M, Jacobsen ED, Davids MS, Kadia TM, Shustov A, Tournilhac O, Bachy E, Zaja F, Porkka K, Hoermann G, Simonitsch-Klupp I, Haferlach C, Kubicek S, Mayerhoefer ME, Hopfinger G, Jaeger U, Dearden C. Staber PB, et al. Blood. 2019 Oct 3;134(14):1132-1143. doi: 10.1182/blood.2019000402. Epub 2019 Jul 10. Blood. 2019. PMID: 31292114 Free PMC article. Review.
T-cell prolymphocytic leukemia (T-PLL) is a rare, mature T-cell neoplasm with a heterogeneous clinical course. ...
T-cell prolymphocytic leukemia (T-PLL) is a rare, mature T-cell neoplasm with a heterogeneous clinical course. .
T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment.
Gutierrez M, Bladek P, Goksu B, Murga-Zamalloa C, Bixby D, Wilcox R. Gutierrez M, et al. Int J Mol Sci. 2023 Jul 28;24(15):12106. doi: 10.3390/ijms241512106. Int J Mol Sci. 2023. PMID: 37569479 Free PMC article. Review.
T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive neoplasm of mature T-cells. ...
T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive neoplasm of mature T-cells. ...
T-cell prolymphocytic leukemia.
Dearden CE. Dearden CE. Clin Lymphoma Myeloma. 2009;9 Suppl 3:S239-43. doi: 10.3816/CLM.2009.s.018. Clin Lymphoma Myeloma. 2009. PMID: 19778847 Review.
T-cell prolymphocytic leukemia is a rare postthymic malignancy with distinctive clinical, morphologic, immunophenotypic, and cytogenetic features. ...
T-cell prolymphocytic leukemia is a rare postthymic malignancy with distinctive clinical, morphologic, immunophe
T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases.
Hu Z, Medeiros LJ, Xu M, Yuan J, Peker D, Shao L, Tang Z, Mai B, Thakral B, Rios A, Hu S, Wang W. Hu Z, et al. Am J Clin Pathol. 2023 Apr 4;159(4):325-336. doi: 10.1093/ajcp/aqac166. Am J Clin Pathol. 2023. PMID: 36883805
OBJECTIVES: T-cell prolymphocytic leukemia (T-PLL) is a rare mature T-cell leukemia usually characterized by inv(14)(q11.2q32)/t(14;14)(q11.2;q32). ...
OBJECTIVES: T-cell prolymphocytic leukemia (T-PLL) is a rare mature T-cell leukemia usually characterized by inv …
Delineation of clinical course, outcomes, and prognostic factors in patients with T-cell prolymphocytic leukemia.
Rose A, Zhang L, Jain AG, Poovathukaran Babu A, Sokol L, Saeed H, Mo Q, Fan W, Zhang X. Rose A, et al. Am J Hematol. 2023 Jun;98(6):913-921. doi: 10.1002/ajh.26918. Epub 2023 Apr 3. Am J Hematol. 2023. PMID: 36964941
T-cell prolymphocytic leukemia (T-PLL) is a rare, post-thymic T-cell neoplasm with a diverse clinical course. ...
T-cell prolymphocytic leukemia (T-PLL) is a rare, post-thymic T-cell neoplasm with a diverse clinical course. ..
T-cell prolymphocytic leukemia: Review of an entity and its differential diagnostic considerations.
Frater JL. Frater JL. Int J Lab Hematol. 2020 Jun;42 Suppl 1:90-98. doi: 10.1111/ijlh.13180. Int J Lab Hematol. 2020. PMID: 32543075 Review.
T-cell prolymphocytic leukemia (T-PLL) is a rare T-cell leukemia characterized in many patients by marked peripheral lymphocytosis, prominent splenomegaly, and skin lesions. ...
T-cell prolymphocytic leukemia (T-PLL) is a rare T-cell leukemia characterized in many patients by marked periph
T-cell prolymphocytic leukemia.
Khot A, Dearden C. Khot A, et al. Expert Rev Anticancer Ther. 2009 Mar;9(3):365-71. doi: 10.1586/14737140.9.3.365. Expert Rev Anticancer Ther. 2009. PMID: 19275513 Review.
T-cell prolymphocytic leukemia is a rare post-thymic lymphoid disorder, which has distinctive clinical, morphologic, immunophenotypic and cytogenetic features. ...
T-cell prolymphocytic leukemia is a rare post-thymic lymphoid disorder, which has distinctive clinical, morpholo
Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
Collignon A, Wanquet A, Maitre E, Cornet E, Troussard X, Aurran-Schleinitz T. Collignon A, et al. Curr Oncol Rep. 2017 Apr;19(4):29. doi: 10.1007/s11912-017-0581-x. Curr Oncol Rep. 2017. PMID: 28324286 Review.
RECENT FINDINGS: B cell prolymphocytic leukemia (B-PLL) diagnosis remains challenging in the absence of clear immunophenotypic or cytogenetic signature and overlap with mantle cell lymphoma. New molecular defects have been identified in T cell prolymphocytic
RECENT FINDINGS: B cell prolymphocytic leukemia (B-PLL) diagnosis remains challenging in the absence of clear immunophenotypic or cytogeneti …
Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene.
Sun S, Fang W. Sun S, et al. Biomed Pharmacother. 2020 Jun;126:110107. doi: 10.1016/j.biopha.2020.110107. Epub 2020 Apr 1. Biomed Pharmacother. 2020. PMID: 32247279 Free article. Review.
T-cell prolymphocytic leukemia (T-PLL) is a rare mature T cell leukemia with aggressive clinical course, poor response to conventional therapies and high mortality rates. ...
T-cell prolymphocytic leukemia (T-PLL) is a rare mature T cell leukemia with aggressive clinical course, poor re
141 results